News

 

ICOpre trademarked in Japan

As part of Iconovos global commercialization plan, we are now strengthening our international IP portfolio by trademarking ICOpre in Japan.…

Iconovo establishes Iconovo Pharma AB as a subsidiary for pharmaceutical sales in the Nordic countries

Iconovo AB (publ), that develops complete inhalation products for a global market, has registered the subsidiary Iconovo Pharma AB with the…
commercialization

Iconovo is recruiting as a drive towards increased commercialization

Iconovo is recruiting two new team members to increase the company's commercialization and is now aiming for one to three new signed contracts…

Iconovo and TOA sign agreement for development of a generic product

Iconovo AB (publ), that develops complete inhalation products for a global market, and TOA Pharmaceutical Co., Ltd, which develops generic…

First granted ICOone® patent in China

The Chinese Patent Office has announced the intention to grant a patent (Notice of Allowance) regarding Iconovo’s inhalation device ICOone. Iconovo…

Iconovo Q3-2021 quarterly report

New nasal inhaler has great potential in treatment of COVID-19 Key figures in TSEK unless otherwise indicated  Jul-Sep 2021 Jul-Sep 2020 Jan-Sep…
bio europe digital event

Meet Iconovo at Bio-Europe Digital

Iconovo will participate at Bio-Europe Digital, an online event that will be held 25-28 October. Here we will present ICOone - our disposable single-dose…

Iconovo develops inhaled Covid-19 vaccine

BBC, and a line of other media channels, has acknowledged Iconovo and its groundbreaking work with immunotherapy company ISR for the development of inhaled…

Iconovo will participate at CPhI Milan

Iconovo will participate at the CPhI event in Milan Italy, 9-11 November 2021. Here thousands of pharma suppliers and buyers unite, connect and do business.…

ICOpre – the story behind a new, generic inhaler platform to Ellipta

Iconovo has developed a new and innovative dry powder inhaler platform - ICOpre - aimed for a global market. ICOpre is a pre-metered dry powder inhaler…